A detailed history of London CO Of Virginia transactions in Pfizer Inc stock. As of the latest transaction made, London CO Of Virginia holds 1,039,070 shares of PFE stock, worth $27.8 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,039,070
Previous 1,070,499 2.94%
Holding current value
$27.8 Million
Previous $30 Million 0.39%
% of portfolio
0.16%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $870,583 - $986,556
-31,429 Reduced 2.94%
1,039,070 $30.1 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $1.45 Million - $1.7 Million
-57,366 Reduced 5.09%
1,070,499 $30 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $3.99 Million - $4.58 Million
154,146 Added 15.83%
1,127,865 $31.3 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $46.6 Million - $60.6 Million
-1,784,711 Reduced 64.7%
973,719 $28 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $145 Million - $169 Million
-4,518,686 Reduced 62.09%
2,758,430 $91.5 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $6.33 Million - $7.32 Million
-175,201 Reduced 2.35%
7,277,116 $267 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $7.82 Million - $10.2 Million
-198,592 Reduced 2.6%
7,452,317 $304 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $174,556 - $227,864
4,181 Added 0.05%
7,650,909 $392 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $8.58 Million - $10.5 Million
196,013 Added 2.63%
7,646,728 $335 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $11.3 Million - $13.5 Million
-243,878 Reduced 3.17%
7,450,715 $391 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $12.1 Million - $15 Million
265,281 Added 3.57%
7,694,593 $398 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $131,025 - $194,223
3,171 Added 0.04%
7,429,312 $439 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $6.78 Million - $8.71 Million
172,670 Added 2.38%
7,426,141 $319 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $2 Million - $2.27 Million
55,739 Added 0.77%
7,253,471 $284 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $370,734 - $418,113
-11,070 Reduced 0.15%
7,197,732 $261 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $2.81 Million - $3.57 Million
83,926 Added 1.18%
7,208,802 $265 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $1.05 Million - $1.23 Million
33,123 Added 0.47%
7,124,876 $261 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $4.87 Million - $5.9 Million
161,522 Added 2.33%
7,091,753 $232 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $8.23 Million - $11.8 Million
-304,625 Reduced 4.21%
6,930,231 $226 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $4.38 Million - $4.97 Million
-132,982 Reduced 1.8%
7,234,856 $283 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $78.7 Million - $102 Million
2,422,576 Added 48.99%
7,367,838 $265 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $792,555 - $889,856
21,432 Added 0.44%
4,945,262 $214 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $3 Million - $3.3 Million
-79,986 Reduced 1.6%
4,923,830 $209 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $14.2 Million - $16.2 Million
-369,579 Reduced 6.88%
5,003,816 $218 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $3.89 Million - $4.72 Million
-112,833 Reduced 2.06%
5,373,395 $237 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $3.4 Million - $3.63 Million
-103,137 Reduced 1.85%
5,486,228 $199 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $22.8 Million - $26.4 Million
-712,957 Reduced 11.31%
5,589,365 $198 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $17.5 Million - $18.6 Million
-525,668 Reduced 7.7%
6,302,322 $228 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $212 Million - $233 Million
6,827,990
6,827,990 $244 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track London CO Of Virginia Portfolio

Follow London CO Of Virginia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of London CO Of Virginia, based on Form 13F filings with the SEC.

News

Stay updated on London CO Of Virginia with notifications on news.